Drawing for TERREMOTO

USPTO serial 97035820

TERREMOTO

Reviewed by CopyMark Law Group

Reg. 8380381Status 700Registered
Filing date
Status date
Registration date
Aug 4, 2026
Examiner
SCHLEGELMILCH, JONATHON A
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with TERREMOTO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John Paul Oleksiuk

John Paul Oleksiuk Cooley LLP1299 Pennsylvania Ave NW, Suite 700Washington, DC 20004United States

Goods and services

ClassDescriptionStatusFirst use
005pharmaceuticals for the prevention and treatment of cancer, oncological diseases, disorders and conditions; pharmaceuticals for the prevention and treatment of blood, hematologic, vascular diseases, disorders and conditions; pharmaceutical preparations and substances for the prevention and treatment of cancer, oncological diseases, disorders and conditions; pharmaceutical preparations and substances for the prevention and treatment of blood, hematologic, vascular, diseases, disorders and conditions; medicines for the prevention and treatment of cancer, oncological diseases, disorders and conditions; medicines for the prevention and treatment of blood, hematologic, vascular diseases, disorders and conditions; drugs for the prevention and treatment of cancer, oncological diseases, disorders and conditions; drugs for the prevention and treatment of blood, hematologic, vascular diseases, disorders and conditions; drug compounds for the prevention and treatment of cancer, oncological diseases, disorders and conditions; drug compounds for the prevention and treatment of blood, hematologic, vascular diseases, disorders and conditions; small molecules for the prevention and treatment of cancer, oncological diseases, disorders and conditions; small molecules for the prevention and treatment of blood, hematologic, vascular diseases, disorders and conditions; therapeutics for the prevention and treatment of cancer, oncological diseases, disorders and conditions; therapeutics for the prevention and treatment of blood, hematologic, vascular diseases, disorders and conditionsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 4, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 4, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 10, 2026SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jul 10, 2026CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jul 10, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jul 9, 2026IUAFUSE AMENDMENT FILED—
Jul 9, 2026EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jun 19, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 18, 2026EX5GSOU EXTENSION 5 GRANTED—
Jun 18, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 3, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 2, 2026EXT5SOU EXTENSION 5 FILED—
Aug 8, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 7, 2025EX4GSOU EXTENSION 4 GRANTED—
Aug 7, 2025EXT4SOU EXTENSION 4 FILED—
Aug 7, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 3, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 27, 2025EX3GSOU EXTENSION 3 GRANTED—
Jan 27, 2025EXT3SOU EXTENSION 3 FILED—
Jan 27, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 6, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 6, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 6, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 13, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 13, 2024EX2GSOU EXTENSION 2 GRANTED—
Aug 13, 2024EXT2SOU EXTENSION 2 FILED—
Aug 13, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 10, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 9, 2024EX1GSOU EXTENSION 1 GRANTED—
Feb 9, 2024EXT1SOU EXTENSION 1 FILED—
Feb 9, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 15, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 20, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 20, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 31, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 11, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 11, 2023XAECEXAMINER'S AMENDMENT ENTERED—
May 11, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 11, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
May 11, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 25, 2023ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Nov 16, 2022GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Nov 16, 2022GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 16, 2022CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 6, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 5, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 5, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 23, 2022ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Apr 5, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 5, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 5, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 25, 2022DOCKASSIGNED TO EXAMINER—
Oct 23, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 23, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance